HK1180955A1 - Heterocyclyl compounds as histamine h3 receptor ligands h3 - Google Patents

Heterocyclyl compounds as histamine h3 receptor ligands h3

Info

Publication number
HK1180955A1
HK1180955A1 HK13108284.3A HK13108284A HK1180955A1 HK 1180955 A1 HK1180955 A1 HK 1180955A1 HK 13108284 A HK13108284 A HK 13108284A HK 1180955 A1 HK1180955 A1 HK 1180955A1
Authority
HK
Hong Kong
Prior art keywords
histamine
receptor ligands
heterocyclyl compounds
heterocyclyl
compounds
Prior art date
Application number
HK13108284.3A
Other languages
English (en)
Chinese (zh)
Inventor
Ramakrishna Nirogi
Anil Karbhari Shinde
Ramasastri Kambhampati
Rambabu Namala
Adi Reddy Dwarampudi
Laxman Kota
Murlimohan Gampa
Padmavathi Kodru
Taraka Naga Vinaykumar Tiriveedhi
Vishwottam Nagaraj Kandikere
Nageshwara Rao Muddana
Ramanatha Shrikantha Saralaya
Pradeep Jayarajan
Dhanalakshmi Shanmuganathan
Ishtiyaque Ahmad
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of HK1180955A1 publication Critical patent/HK1180955A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK13108284.3A 2010-09-02 2013-07-15 Heterocyclyl compounds as histamine h3 receptor ligands h3 HK1180955A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2551CH2010 2010-09-02
PCT/IN2010/000740 WO2012029070A1 (fr) 2010-09-02 2010-11-15 Composés hétérocyclyle comme ligands des récepteurs h3 de l'histamine

Publications (1)

Publication Number Publication Date
HK1180955A1 true HK1180955A1 (en) 2013-11-01

Family

ID=43608695

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13108284.3A HK1180955A1 (en) 2010-09-02 2013-07-15 Heterocyclyl compounds as histamine h3 receptor ligands h3

Country Status (27)

Country Link
US (1) US8912179B2 (fr)
EP (1) EP2611444B1 (fr)
JP (1) JP5650329B2 (fr)
KR (1) KR101538239B1 (fr)
CN (1) CN103079566B (fr)
AU (1) AU2010360038B2 (fr)
BR (1) BR112013005084A2 (fr)
CA (1) CA2812970C (fr)
CY (1) CY1117096T1 (fr)
DK (1) DK2611444T3 (fr)
EA (1) EA022746B1 (fr)
ES (1) ES2558531T3 (fr)
HK (1) HK1180955A1 (fr)
HR (1) HRP20151380T1 (fr)
HU (1) HUE028435T2 (fr)
IL (1) IL224652A (fr)
ME (1) ME02320B (fr)
MX (1) MX354852B (fr)
NZ (1) NZ607658A (fr)
PL (1) PL2611444T3 (fr)
PT (1) PT2611444E (fr)
RS (1) RS54514B1 (fr)
SG (1) SG188212A1 (fr)
SI (1) SI2611444T1 (fr)
SM (1) SMT201600012B (fr)
WO (1) WO2012029070A1 (fr)
ZA (1) ZA201301143B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2888243B1 (fr) * 2012-08-23 2016-08-17 Suven Life Sciences Limited Composés acrylamides utilisés comme ligands des récepteurs h3 à l'histamine
CN104530088A (zh) * 2014-12-08 2015-04-22 苏州施亚生物科技有限公司 2-氨基-6,7-二氢-5H-噻唑并[5,4-b]吡啶-4-羧酸叔丁酯及其衍生物,以及它们的合成方法
EP3378477A1 (fr) * 2017-03-21 2018-09-26 BIOPROJET Pharma Nouvelles utilisations thérapeutiques de ligands h3
AR113826A1 (es) 2017-11-02 2020-06-17 Aicuris Gmbh & Co Kg Indol-2-carboxamidas sustituidas con amino-tiazol activas contra el virus de la hepatitis b (vhb)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695575A (en) 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
PH23995A (en) 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
DE60234453D1 (de) 2001-07-02 2009-12-31 High Point Pharmaceuticals Llc Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
CA2497827A1 (fr) 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Composes heterocycliques
AU2005263719A1 (en) * 2004-07-16 2006-01-26 Janssen Pharmaceutica N.V. Dimeric piperidine derivatives
EA200700254A1 (ru) * 2004-07-16 2007-06-29 Янссен Фармацевтика Н. В. Димерные производные пипередина
MX2007011211A (es) * 2005-03-14 2007-10-17 Glaxo Group Ltd Derivados de tiazol fusionado que tienen afinidad para el receptor h3 de histamina.
AU2007229492B2 (en) * 2006-03-28 2011-11-03 High Point Pharmaceuticals, Llc Benzothiazoles having histamine H3 receptor activity
US20100009969A1 (en) * 2006-07-27 2010-01-14 Ucb Pharma, S.A. Fused Oxazoles & Thiazoles As Histamine H3- Receptor Ligands
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US7557101B2 (en) * 2006-12-08 2009-07-07 Hoffman-La Roche Inc. 4,5,6,7-tetrahydro-thieno[3,2-c] pyridine derivatives
US20080146559A1 (en) * 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
WO2009092764A1 (fr) * 2008-01-24 2009-07-30 Ucb Pharma, S.A. Composés comprenant un groupe cyclobutoxy
WO2010026113A1 (fr) 2008-09-03 2010-03-11 Evotec Neurosciences Gmbh Acyl- et sufonyl-tétrahydronaphtyridines et dérivés aza de celles-ci en tant qu’antagonistes de récepteur d’histamine h3

Also Published As

Publication number Publication date
EA201390327A1 (ru) 2013-08-30
DK2611444T3 (en) 2016-01-11
CA2812970C (fr) 2015-01-13
SMT201600012B (it) 2016-02-25
SI2611444T1 (sl) 2016-04-29
SG188212A1 (en) 2013-04-30
ES2558531T3 (es) 2016-02-05
BR112013005084A2 (pt) 2020-08-25
NZ607658A (en) 2014-02-28
HUE028435T2 (en) 2016-12-28
WO2012029070A1 (fr) 2012-03-08
JP2013536834A (ja) 2013-09-26
ME02320B (me) 2016-06-20
CA2812970A1 (fr) 2012-03-08
CN103079566A (zh) 2013-05-01
KR101538239B1 (ko) 2015-07-20
CY1117096T1 (el) 2017-04-05
KR20130042605A (ko) 2013-04-26
EP2611444B1 (fr) 2015-10-14
MX354852B (es) 2018-03-22
HRP20151380T1 (hr) 2016-01-15
JP5650329B2 (ja) 2015-01-07
RS54514B1 (en) 2016-06-30
MX2013001988A (es) 2013-05-09
AU2010360038A1 (en) 2013-04-04
PT2611444E (pt) 2016-02-04
EA022746B1 (ru) 2016-02-29
PL2611444T3 (pl) 2016-03-31
US20140148440A1 (en) 2014-05-29
US8912179B2 (en) 2014-12-16
CN103079566B (zh) 2015-06-17
IL224652A (en) 2016-05-31
EP2611444A1 (fr) 2013-07-10
ZA201301143B (en) 2013-10-30
AU2010360038B2 (en) 2014-05-15

Similar Documents

Publication Publication Date Title
HRP20181788T1 (hr) Supstituirani spojevi piridinon-piridinil
AP3391A (en) 2-Amino-4-arylthiazole compounds as TROA1 antagonists
PL2611300T3 (pl) Podstawione skondensowane pochodne dihydropirymidynonów
EP2709609A4 (fr) Composés hétérocycliques
HK1187613A1 (en) Compounds as histamine h3 receptor ligands h3
HK1203938A1 (en) Novel 2h-indazoles as ep2 receptor antagonists ep2 2h-
AP3307A (en) Heteroaryl compounds as 5-HT4 receptor ligands
HK1180955A1 (en) Heterocyclyl compounds as histamine h3 receptor ligands h3
HK1204620A1 (en) Acrylamide compounds as histamine h3 receptor ligands h3
GB2501403B (en) 3-arylethynyl substituted quinazolinone compounds
ZA201409244B (en) Acrylamide compounds as histamine h3 receptor ligands
GB201015784D0 (en) Anti-cancer compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201120